Updates and perspectives from our industry experts, scientists and product leaders.
Discover why AAV vectors are key to gene therapy success, offering precise delivery, wide clinical applications, and transformative impact in genetic disease treatment.
Uncover the emerging role of AI in gene therapy and how it is paving the way for groundbreaking advancements.
Discover how Form Bio and Google Cloud’s Multiomics Suite will empower life scientists to accelerate research, development, and pre-clinical studies in personalized medicine and gene therapies.
Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.
Claire Aldridge, PhD
February 6, 2024
2024-02-06
Joe Nipko, PhD
December 6, 2023
2023-12-06
Chris Haas
June 13, 2023
2023-06-13
Nick Ketz, PhD
May 3, 2023
2023-05-03
Andrew Busey & Kent Wakeford
March 27, 2023
2023-03-27
Austin Day, PhD
February 10, 2023
2023-02-10
Anusha Sriraman, PhD
April 23, 2024
2024-04-23
Explore Form Bio's AI models that predict, optimize, and de-risk AAV vector design outcomes.
Angela Anderson
April 18, 2024
2024-04-18
Meet the members of Form Bio’s new Scientific Advisory Board, helping to guide our groundbreaking cell and gene therapy innovation.
March 26, 2024
2024-03-26
Discover key strategies and guidelines for compliance in gene therapy research with BGTC's AAV Gene Therapy Regulatory Playbook.
March 14, 2024
2024-03-14
Explore how to navigate the complexities of multiomics data analysis in life science with our innovative solutions that empower researchers and accelerate R&D processes in the field.
March 5, 2024
2024-03-05
Discover how harmonizing AAV, AI, and biological data is revolutionizing gene therapy development, paving the way for safe and effective treatments.
Jill Roughan, PhD
February 20, 2024
2024-02-20
See how process optimization for AAV gene therapies ensure higher efficiency and quality in every batch.
Discover the progression of AI from inception to present-day, and how it powers the efficient analysis of big data, revolutionizes gene therapy development, and advances biomanufacturing.